Medica-Plus: a Micromegas-based proof-of-concept detector for sub-becquerel tritium activity assessment at the service of oncological research

Autor: Jambon, F., Aune, S., Baron, P., Benoit, T., Bey, T., Desforge, D., Ferrer-Ribas, E., Grabas, A., Kebbiri, M., Mandjavidze, I., Papaevangelou, T., Riallot, M., Vandenbroucke, M., Beau, F., Dive, V., Malgorn, C., Malloggi, F., Rousselot, A., Carrel, F., Trocmé, M.

To fulfill needs in oncological research a new Micromegas detector has been developed to follow radiolabelled drugs in living organisms at the single cell level. This article describes the proof-of-concept of such a detector and compares its ability

Externí odkaz: http://arxiv.org/abs/2109.09411

Medica-Plus: A Micromegas-based proof-of-concept detector for sub-becquerel tritium activity assessment at the service of oncological research

Autor: Jambon, F., Aune, S., Baron, P., Benoit, T., Bey, T., Desforge, D., Ferrer-Ribas, E., Grabas, A., Kebbiri, M., Mandjavidze, I., Papaevangelou, T., Riallot, M., Vandenbroucke, M., Beau, F., Dive, V., Malgorn, C., Malloggi, F., Rousselot, A., Carrel, F., Trocmé, M.

Publikováno v: In Nuclear Inst. and Methods in Physics Research, A 11 March 2022 1027

X-ray imaging with Micromegas detectors with optical readout

Autor: Cools, A., Aune, S., Beau, F., Brunbauer, F.M., Benoit, T., Desforge, D., Ferrer-Ribas, E., Kallitsopoulou, A., Malgorn, C., Oliveri, E., Papaevangelou, T., Pollacco, E.C., Ropelewski, L., Sari, A., Iguaz, F.J.

Publikováno v: MPGD 2022-The 7th International Conference on Micro Pattern Gaseous Detectors
MPGD 2022-The 7th International Conference on Micro Pattern Gaseous Detectors, RD51 at CERN; Weizmann Institute of Science, Dec 2022, Rehovot, Israel

In the last years, optical readout of Micromegas gaseous detectors has been achieved by implementing a Micromegas detector on a glass anode coupled to a CMOS camera. Effective X-ray radiography was demonstrated using integrated imaging approach. High

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8843d129662f305fa205fb0bb303b4
https://hal.science/hal-04076724/document

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The newly identified striatal marker Doublecortin-like kinase 3 (Dclk3) may be amolecular determinant of striatal vulnerability in Huntington’s disease

Autor: Francelle, L., Galvan, Laurie, Gaillard, M.-C, Liot, G., de Chaldée d'Abbas, M, Guillermier, M., Houitte, D., Chaigneau, M., Joséphine, C, Bonvento, G., Malgorn, C, Petit, F, Jan, C, Dufour, N, Elalouf, J.-M, Humbert, S, Saudou, F, Déglon, N, Brouillet, E

Publikováno v: SFN 2013
SFN 2013, Nov 2013, SAN DIEGO, United States

International audience; Huntington's disease (HD) is an inherited neurodegenerative disorder caused by an abnormal polyglutamine expansion in the protein huntingtin (htt). Mutant htt, despite its ubiquitous expression in the brain, leads to preferent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8f580c5e1842c8361104bf1b889a9496
https://hal.archives-ouvertes.fr/hal-02534692